These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24979756)

  • 21. Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma.
    Wright JH; Johnson MM; Shimizu-Albergine M; Bauer RL; Hayes BJ; Surapisitchat J; Hudkins KL; Riehle KJ; Johnson SC; Yeh MM; Bammler TK; Beyer RP; Gilbertson DG; Alpers CE; Fausto N; Campbell JS
    Int J Cancer; 2014 Feb; 134(4):778-88. PubMed ID: 23929039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
    Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
    Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TNFR1 determines progression of chronic liver injury in the IKKγ/Nemo genetic model.
    Cubero FJ; Singh A; Borkham-Kamphorst E; Nevzorova YA; Al Masaoudi M; Haas U; Boekschoten MV; Gassler N; Weiskirchen R; Muller M; Liedtke C; Trautwein C
    Cell Death Differ; 2013 Nov; 20(11):1580-92. PubMed ID: 23933814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perturbation of Specific Signaling Pathways Is Involved in Initiation of Mouse Liver Fibrosis.
    Chen L; Guo P; Li W; Fang F; Zhu W; Fan J; Wang F; Gao Y; Zhao Q; Wang Q; Xiao Y; Xing X; Li D; Shi T; Yu D; Aschner M; Zhang L; Chen W
    Hepatology; 2021 Apr; 73(4):1551-1569. PubMed ID: 32654205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of hepatic stem cells compartment during hepatocarcinogenesis in a HBsAg HBV-transgenic mouse model.
    Anfuso B; El-Khobar KE; Ie SI; Avellini C; Radillo O; Raseni A; Tiribelli C; Sukowati CHC
    Sci Rep; 2018 Sep; 8(1):13168. PubMed ID: 30177788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of TNF and Fas dependent signaling in animal models of inflammatory liver injury and liver cancer.
    Liedtke C; Trautwein C
    Eur J Cell Biol; 2012; 91(6-7):582-9. PubMed ID: 22153863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nor-ursodeoxycholic acid reverses hepatocyte-specific nemo-dependent steatohepatitis.
    Beraza N; Ofner-Ziegenfuss L; Ehedego H; Boekschoten M; Bischoff SC; Mueller M; Trauner M; Trautwein C
    Gut; 2011 Mar; 60(3):387-96. PubMed ID: 21115542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disruption of the FasL/Fas axis protects against inflammation-derived tumorigenesis in chronic liver disease.
    Cubero FJ; Woitok MM; Zoubek ME; de Bruin A; Hatting M; Trautwein C
    Cell Death Dis; 2019 Feb; 10(2):115. PubMed ID: 30737368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid-encapsulated siRNA for hepatocyte-directed treatment of advanced liver disease.
    Woitok MM; Zoubek ME; Doleschel D; Bartneck M; Mohamed MR; Kießling F; Lederle W; Trautwein C; Cubero FJ
    Cell Death Dis; 2020 May; 11(5):343. PubMed ID: 32393755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic Stellate Cells Improve Engraftment of Human Primary Hepatocytes: A Preclinical Transplantation Study in an Animal Model.
    Dusabineza AC; Najimi M; van Hul N; Legry V; Khuu DN; van Grunsven LA; Sokal E; Leclercq IA
    Cell Transplant; 2015; 24(12):2557-71. PubMed ID: 25706818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of caspase-8 protects mice against inflammation-related hepatocarcinogenesis but induces non-apoptotic liver injury.
    Liedtke C; Bangen JM; Freimuth J; Beraza N; Lambertz D; Cubero FJ; Hatting M; Karlmark KR; Streetz KL; Krombach GA; Tacke F; Gassler N; Riethmacher D; Trautwein C
    Gastroenterology; 2011 Dec; 141(6):2176-87. PubMed ID: 21878202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement of hepatocyte transplantation efficiency in the mdr2-/- mouse model by glyceryl trinitrate.
    Boudechiche L; Tranchart H; Branchereau S; Davit-Spraul A; Laïnas P; Groyer-Picard MT; Weber A; Hadchouel M; Dagher I
    Transplantation; 2015 Jan; 99(1):36-40. PubMed ID: 25340599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of Cyclin E1 attenuates hepatitis and hepatocarcinogenesis in a mouse model of chronic liver injury.
    Ehedego H; Mohs A; Jansen B; Hiththetiya K; Sicinski P; Liedtke C; Trautwein C
    Oncogene; 2018 Jun; 37(25):3329-3339. PubMed ID: 29551768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocyte-specific TAK1 deficiency drives RIPK1 kinase-dependent inflammation to promote liver fibrosis and hepatocellular carcinoma.
    Tan S; Zhao J; Sun Z; Cao S; Niu K; Zhong Y; Wang H; Shi L; Pan H; Hu J; Qian L; Liu N; Yuan J
    Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14231-14242. PubMed ID: 32513687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stem cell and hepatocyte proliferation in hepatitis C cirrhosis and hepatocellular carcinoma: transplant implications.
    Behnke MK; Reimers M; Fisher RA
    Ann Hepatol; 2013 Jan-2014 Feb; 13(1):45-53. PubMed ID: 24378265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic overexpression of cAMP-responsive element modulator α induces a regulatory T-cell response in a murine model of chronic liver disease.
    Kuttkat N; Mohs A; Ohl K; Hooiveld G; Longerich T; Tenbrock K; Cubero FJ; Trautwein C
    Gut; 2017 May; 66(5):908-919. PubMed ID: 27686093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional role of CCL5/RANTES for HCC progression during chronic liver disease.
    Mohs A; Kuttkat N; Reißing J; Zimmermann HW; Sonntag R; Proudfoot A; Youssef SA; de Bruin A; Cubero FJ; Trautwein C
    J Hepatol; 2017 Apr; 66(4):743-753. PubMed ID: 28011329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional mouse hepatocytes derived from interspecies chimeric livers effectively mitigate chronic liver fibrosis.
    Huang C; Jiang H; Dong J; Jiang L; Li J; Xu J; Cui T; Wang L; Li X; Feng G; Zhang Y; Li T; Li W; Zhou Q
    Stem Cell Reports; 2024 Jun; 19(6):877-889. PubMed ID: 38729156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The contribution of toll-like receptor signaling to the development of liver fibrosis and cancer in hepatocyte-specific TAK1-deleted mice.
    Song IJ; Yang YM; Inokuchi-Shimizu S; Roh YS; Yang L; Seki E
    Int J Cancer; 2018 Jan; 142(1):81-91. PubMed ID: 28875549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic differentiation of human amniotic epithelial cells and in vivo therapeutic effect on animal model of cirrhosis.
    Lin JS; Zhou L; Sagayaraj A; Jumat NH; Choolani M; Chan JK; Biswas A; Wong PC; Lim SG; Dan YY
    J Gastroenterol Hepatol; 2015 Nov; 30(11):1673-82. PubMed ID: 25973537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.